A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

NCT02323178 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

CMML
Thrombocytopenia

Interventions

DRUG: eltrombopag

Sponsor

Groupe Francophone des Myelodysplasies

Collaborators

[object Object]
[object Object]